Personalized medicine begins with understanding patterns.

Tapley Holland describes how analyzing more than 13,000 blood data points helped reveal consistent relationships between platelet counts and different disease states. These observations became the foundation for developing TruDOSE’s individualized dosing approach.

Rather than applying the same platelet dose to every patient, TruDOSE measures each person’s platelet count to help determine an appropriate treatment strategy.

The goal is to make platelet therapy more measurable, repeatable, and personalized.

Key Insights

• Large clinical datasets helped shape TruDOSE.
• Platelets play an important role in cellular communication.
• Personalized dosing is based on measurable biological information.